A wearable device claiming to block the pain of opioid withdrawal has been cleared by the Food and Drug Administration under a new expedited review process.
Mark Smith wants to inject his dying daughter with a virus in hopes it might kill the bacteria rooted in her lungs. First, he has to find the right virus.
New findings highlight just how hard it has been for the FDA to keep potentially unsafe supplement ingredients off the market.
New interior design programs train students to use lighting, acoustics, and fabric to make day-to-day living easier for people with medical conditions.
The time of day of your surgery could have long-term impacts on your health.
The danger of natural disasters lies not only in the tremendous loss of life and property, but also in the psychological toll they take on survivors.
An experimental vaccine meant to combat peanut allergy came up short in a large clinical trial, but the company still hopes it can win FDA approval.
As the first gene therapies approach the market, drug makers, insurers, and patients are debating complex questions about cost, value, and payment plans.
WASHINGTON — If House Speaker Paul Ryan comes down with the flu this winter, he and his security detail won’t be screeching off toward the closest CVS for his Tamiflu. Instead, he can just walk downstairs and pick up the…
A hepatitis A outbreak that has stricken 481 people in San Diego could get worse because of the challenges of dealing with the homeless population.
Support PBS NewsHour:
